A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men with prostate cancer, especially ...
Feb 26, 2026
0
0
EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening the door to future clinical ...
Feb 26, 2026
0
0
A new study led by Swansea University has mapped international evidence on the outcomes of children who grow up in out-of-home care. Drawing on 77 reviews, published between January 2013 and July 2024, research, shows which ...
Feb 26, 2026
0
0
Researchers from the Critical Analytics for Manufacturing Personalized Medicine (CAMP), an interdisciplinary research group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), in collaboration with Massachusetts ...
Feb 26, 2026
0
0
Organ donation after the heart stops beating, a practice called donation after circulatory death, has gone from rare to routine in the United States, a new study shows. This shift over the past 25 years, aided by technological ...
Feb 26, 2026
0
0
An international clinical trial has found that an oral form of semaglutide, a widely used diabetes drug, reduced the risk of serious heart failure events in people with type 2 diabetes who already had heart failure. The findings, ...
Feb 26, 2026
0
0
Music is commonly used during exercise and is often assumed to improve focus, mood, or mental performance. A new systematic review and meta-analysis led by researchers at the Centre of Excellence in Music, Mind, Body and ...
Feb 26, 2026
0
0
Cancer treatment can take a profound financial toll, and new research shows the damage does not stop at the bank account. Nearly half of patients experience significant "financial toxicity," and that strain quietly chips ...
Feb 26, 2026
0
0
A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 randomized controlled trial ...
Feb 26, 2026
0
0
Despite major advances in diagnostics and treatment, tuberculosis (TB) remains the world's deadliest infectious disease. In a new study published in The Lancet Global Health, researchers from Ludwig Maximilian University ...
Feb 26, 2026
0
0
